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Pyroptosis is a caspase-1-dependent pro-inflammatory form of programmed cell death 
implicated in the pathogenesis of autoinflammatory diseases known as cryopyrin-
associated periodic syndromes (CAPS), as well as in disorders characterised by 
excessive cell death and chronic inflammation, such as rheumatic and 
neurodegenerative diseases (1, 2). Activation of NLRP3 inflammasome is a key event 
in the regulation of the pyroptotic cascade. 
The aim of this study was the design of new compounds able to interfere with 
NLRP3-promoted pyroptotic cascade. A library of 36 compounds was synthesised 
using an electrophilic fragment-based strategy. Pyroptosis was studied in phorbol 
myristate acetate-differentiated and LPS-primed THP-1 cells (a model of activated 
human macrophages) exposed to ATP (5 mM; 1 h) or nigericin (10 µM, 1.5 h). 
Pyroptotic cell death was evidenced through microscopic examination of cellular 
morphology and evaluated by measuring the increase in lactate dehydrogenase 
activity in the collected supernatants. Pyroptosis of THP-1 cells was significantly 
prevented (p<0.05 vs. vehicle alone, ANOVA and Bonferroni’s post-test) by most of 
the synthesised compounds with an efficacy ranging from 12.1±1.2% to 97.9±5.7%. 
Cytotoxicity of new compounds was evaluated by measuring viability of human renal 
epithelial cells (HK-2) by MTT assay. 
The anti-pyroptotic effect proved to be both time- and dose-dependent with best 
performing compounds exhibiting EC50 values in the submicromolar range. The 
ability of model compounds to react, in vitro, with biologically relevant thiol groups 
was then proved using 1H-NMR spectroscopy and gluthatione as the probe. 
Preliminary insights into the mechanism of action of selected derivatives showed that 
they prevent pyroptosis by interfering with the NLRP3 inflammasome function. 
In conclusion, our results not only identify a molecular scaffold suitable for 
developing druggable compounds, but also indicate the role of reactive cysteine 
residues in the NLRP3 inflammasome regulatory mechanisms. 
Time-course and concentration-response
curves for the effects of representative
compounds on the ATP-triggered cell death
of THP-1 cells. (A) For the time-course
experiments each compound was added at
10 µM, 15-90 min before exposure to ATP
(5 mM; 1 h). (B) For the concentration-
response experiments each compounds
was added at increasing concentrations
(0.001-10 µM) 1 h before exposure to ATP
(5 mM; 1 h). The effects of compound 5
(), 8, (), 9 (), 10 (), 32 (), 33 (),
41 (), and 42 () are shown.0 15 30 45 60 75 900
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